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Abstract
Hypervirulent strains of Clostridium difficile have emerged over the past decade, increasing the morbidity and mortality of
patients infected by this opportunistic pathogen. Recent work suggested the major C. difficile virulence factor, TcdB, from
hypervirulent strains (TcdBHV) was more cytotoxic in vitro than TcdB from historical strains (TcdBHIST). The current study
investigated the in vivo impact of altered TcdB tropism, and the underlying mechanism responsible for the differences in
activity between the two forms of this toxin. A combination of protein sequence analyses, in vivo studies using a Danio rerio
model system, and cell entry combined with fluorescence assays were used to define the critical differences between
TcdBHV and TcdBHIST. Sequence analysis found that TcdB was the most variable protein expressed from the pathogenicity
locus of C. difficile. In line with these sequence differences, the in vivo effects of TcdBHV were found to be substantially
broader and more pronounced than those caused by TcdBHIST. The increased toxicity of TcdBHV was related to the toxin’s
ability to enter cells more rapidly and at an earlier stage in endocytosis than TcdBHIST. The underlying biochemical
mechanism for more rapid cell entry was identified in experiments demonstrating that TcdBHV undergoes acid-induced
conformational changes at a pH much higher than that of TcdBHIST. Such pH-related conformational changes are known to
be the inciting step in membrane insertion and translocation for TcdB. These data provide insight into a critical change in
TcdB activity that contributes to the emerging hypervirulence of C. difficile.
Citation: Lanis JM, Barua S, Ballard JD (2010) Variations in TcdB Activity and the Hypervirulence of Emerging Strains of Clostridium difficile. PLoS Pathog 6(8):
e1001061. doi:10.1371/journal.ppat.1001061
Editor: Michael S. Gilmore, Harvard Medical School, United States of America
Received April 27, 2010; Accepted July 22, 2010; Published August 19, 2010
Copyright:  2010 Lanis et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by a grant from the National Institutes of Health awarded to JDB (R01HL084489). The funders had no role in study design,
data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: jimmy-ballard@ouhsc.edu
Introduction
Clostridium difficile is a gram-positive, spore-forming anaerobe,
first described by Hall and O’Toole over 75 years ago [1];
however, the organism was not associated with human disease
until 1978 [2,3]. Over the past three decades C. difficile has become
a major nosocomial pathogen and is the leading cause of diarrhea
in hospitalized patients [4]. C. difficile associated disease (CDAD) is
routinely treated by supportive therapy and regimens of
vancomycin and metronidazole, but treatment of CDAD has
become more difficult due to the emergence of hypervirulent
(NAP1/BI/027) strains of C. difficile [5,6,7]. Elucidating the major
differences between historical strains of C. difficile and the NAP1/
BI/027-related strains of C. difficile is critical to understanding how
this serious human pathogen continues to emerge.
The phenotypes of hypervirulent and historical strains of C.
difficile are different [7,8,9]. C. difficile NAP1/BI/027 produces
more toxin and sporulates with higher efficiency than historical
strains [6,7,8,9,10]. NAP1/BI/027 strains also produce a binary
toxin, CDT, which is thought to enhance colonization of C. difficile
by triggering the formation of microtubule protrusions on cells of
the gastrointestinal epithelium [11,12,13]. Finally, C. difficile
NAP1/BI/027 strains are resistant to fluoroquinolones due to
mutations in DNA gyrase genes [7,14,15,16]. The extent to which
one or more of these differences between the two strains
contributes to hypervirulence has not been determined.
Recent work from Stabler and colleagues identified several
genetic variations between epidemic and historical strains of C.
difficile [17]. For example, the historical C. difficile strain, 630, was
found to contain 505 unique coding sequences compared to
hypervirulent strains. This analysis also identified differences in
flagellar genes, metabolic genes, phage islands, and transcriptional
regulators. Of interest to our work was the finding that TcdB from
C. difficile hypervirulent strains had a greater cytopathic effect on a
variety of cell types than TcdB isolated from a C. difficile historical
strain. The steps in cellular intoxication that account for these
differences in TcdB activity, and whether in vivo tropism varies
between the historical and hypervirulent TcdB have not been
reported.
TcdB (,269 kDa) is a 2366 residue single polypeptide toxin
encoded on a C. difficile pathogenicity locus (PaLoc) that also
includes genes for two regulators (TcdC and TcdR) of toxin
expression, a putative holin (TcdE), and TcdA [18,19]. TcdB has
at least four functional domains that contribute to cell entry and
glucosylation of small-GTPases within the cytosol of the cell [20].
TcdB’s glucosyltransferase domain is included in the first 516
residues of the toxin, which also includes a conserved DXD motif
(Asp286/Asp288) and Trp102, which form a complex with Mn
2+
and UDP-Glucose [21,22,23,24,25]. A substrate recognition
domain is located between residues 365–516 [26]. The cysteine
protease domain at residues 544–955 is necessary for autoproteo-
lytic activity and delivery of the enzymatic domain into the cytosol
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between residues 956–1128, yet whether this domain is required
for intoxication is not known. Finally, the fourth functional
domain of TcdB is located within the carboxy-terminal region of
the toxin, and is predicted to interact with receptors on target cells
[30,31,32,33].
Sequence variations in one or more of the functional domains of
TcdB could account for the differences in cytotoxicity between
historical and hypervirulent isolates. In the current work we test
this hypothesis and demonstrate that TcdB from hypervirulent
strains exhibits broader tropism in vivo. We also demonstrate
TcdB from hypervirulent C. difficile undergoes hydrophobic
conformational changes at a higher pH than toxin from the
historical strain, and this correlates with more rapid cell entry.
These findings provide insight into a possible mechanism through
which hypervirulent C. difficile causes more severe illness than
historical strains of this organism.
Results
Sequence comparison of the functional domains of TcdB
from a historical strain (TcdBHIST) and TcdB from a
hypervirulent strain (TcdBHV)
The carboxy-terminal sequence of TcdB varies between isolates
of C. difficile, including hypervirulent and historical strains [17,34].
Yet, whether sequence variations are more extensive in TcdB
compared to other genes in the PaLoc or if the sequences outside
of the carboxy-terminal domain of TcdB also varied among
different strains of C. difficile has not been reported.
We compared the sequences of proteins encoded within the
PaLoc of C. difficile 630 (a non-NAP1/BI/027 strain) and C. difficile
R20291 (a 027 strain). The sequence of TcdR, a positive regulator
of toxin expression was found to be 100% identical between the
two strains of C. difficile. TcdE, the putative holin encoded in the
middle of the PaLoc exhibited 99% identity and 100% similarity
between the two strains of C. difficile. The enterotoxin, TcdA,
exhibited 98% identity and 99% similarity between the two
strains. The gene encoding TcdC from the hypervirulent strain
encodes a stop codon and contains a deletion, which made it
difficult to precisely compare this protein in the two strains.
However, at the DNA level the gene was 95% homologous in the
intact coding regions of tcdC. In contrast to these almost exact
identities of TcdR, TcdE, and TcdA from the two strains, the
amino-acid sequence of TcdB from the two strains was found to
have the most variation with 92% identity and 96% similarity.
We next compared the functional regions of TcdBHIST and
TcdBHV (Fig. 1). The enzymatic region of TcdB (encompassing
residues 1–543) was found to be 96% identical and 98% similar
between the two strains of C. difficile. Residues critical for catalytic
activity, W102 and the DXD motif, did not vary between the two
forms of TcdB (Fig. 1A). The substrate specificity domain of TcdB
(residues 365 to 516) [26] exhibited 99% identity and 100%
similarity (Fig. 1A). The autoproteolytic region (residues 544 to
955) was found to contain 96% identity and 98% similarity.
Moreover, the reported catalytic triad (D587, H653, and C698)
was conserved between the two forms of TcdB. Interestingly
however, the analysis found a rearrangement of a second cysteine
residue in this region of TcdB. TcdBHIST contains a cysteine at
residue 870, but this residue is a tyrosine in TcdBHV (Fig. 1B).
Conversely, TcdBHV has a cysteine residue at 1477, but this was
found to be a glycine residue in TcdBHIST. The third putative
functional domain of TcdB is between residues 956 and 1644, and
encodes a hydrophobic region thought to mediate membrane
insertion. Comparison of this region found 91% identity and 96%
similarity (Fig. 1C).
In line with earlier reports [17,34] the carboxy-terminal region,
encompassing residues 1645 to 2366, exhibited the highest degree
of sequence variation in the toxin. The carboxy-terminal region
showed 88% identity and 95% similarity between the two forms of
TcdB. The number of CROP regions is identical, with TcdBHIST
and TcdBHV containing 24 regions based on the YF consensus
motif [30,32,35,36]. However, eight of these regions in TcdBHV
were found to exhibit less than 80% sequence identity to
TcdBHIST (Fig. 1D).
Fig. 1E shows an SDS-PAGE analysis of TcdBHIST and
TcdBHV purified from wild-type strains of C. difficile as described
in the materials and methods. Both forms of the toxin were
obtained at greater than 95% purity based on minimal detection of
contaminating proteins.
In vivo assessment of TcdBHIST and TcdBHV
We next used a zebrafish model to compare the in vivo effects of
the two forms of this toxin. Our group has previously utilized the
zebrafish embryo as a model to examine the effects of TcdBHIST in
real time, and found that this toxin had potent cardiotoxic effects
[37]. The zebrafish provides a distinct advantage for the purpose
of examining tissue damage and tropism because it is possible to
visualize these events directly with this model.
Zebrafish embryos were arrayed in a 48-well plate in embryo
water and TcdBHIST or TcdBHV across a range of concentrations
was applied to the individual wells. At 24 h following treatment, a
minimum of 20 zebrafish larvae per condition were examined by
light microscopy for physiological changes, tissue damage, and
viability (Fig. 2). Extensive necrosis was evident in all embryos
exposed to TcdBHV, with broad tissue damage caused to the yolk
sac, body, and head at concentrations as low as 1 nM (Fig. 2B and
2D). Furthermore, all zebrafish treated with TcdBHV succumbed
to the effects of the toxin within 48 h. In contrast, treatment with
TcdBHIST resulted in more specific damage at the cardiac region
in approximately 75% of embryos, and was not immediately lethal
(Fig. 2A). Incubation with higher doses of TcdBHIST or for longer
periods of time increased toxicity but did not alter the
Author Summary
Clostridium difficile is a spore-forming bacterium that
contaminates hospitals and infects patients undergoing
antibiotic therapy. C. difficile is now the leading cause of
hospital-acquired diarrhea in developed countries. Most
concerning has been the recent increase in mortality of C.
difficile patients due to the emergence of a hypervirulent
strain of this pathogen. Results from the current study
suggest this change in disease severity may be due to new
strains producing a variant form of C. difficile’s major
virulence factor, TcdB. The findings indicate TcdB from
hypervirulent strains targets a much broader range of cells
in vivo and is able to translocate into target cells more
quickly than TcdB from historical strains of C. difficile. The
more rapid cell entry by TcdB from hypervirulent C. difficile
appears to be due to the toxin’s capacity to undergo
conformational changes necessary for membrane translo-
cation at a higher pH than TcdB from historical strains. To
date, very little has been learned about the underlying
reasons for the increased virulence of emerging C. difficile
strains. These findings provide insight into this problem
and suggest variations in TcdB activity could be an
important contributing factor to the hypervirulence of
emerging strains of C. difficile.
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TcdBHV impacts a broader number of cell types in vivo compared
to TcdBHIST. However, corresponding to our previous report
TcdBHIST preferentially targets cardiac cells in the zebrafish
embryo system.
Recent studies determined the relative cytotoxicity of TcdBHV
and TcdBHIST on eight different cell types [17]. Because this
analysis did not include cells of cardiac lineage, we compared the
two toxins on HL-1 cells, which are derived from mouse cardiac
tissue [38]. We also examined the effects of the two toxins on
CHO cells for a relative comparison to the cardiomyocytes. As
shown in Fig. 3, similar to previous observations, TcdBHV was
more cytotoxic to CHO cells (TCD50 2.37610
213 M) than was
TcdBHIST (TCD50 2.53610
211 M). In contrast, TcdBHV was not
more cytotoxic on cardiomyocytes and displayed a very similar
activity to TcdBHIST. Upon further investigation of the cardio-
myocytes, the cytotoxicity of TcdBHV was found to be slightly
lower than TcdBHIST (p,0.05) with a TCD50 approximately 10-
fold higher (3.37610
210 M) than TcdBHIST (TCD50
2.80610
211 M). These data indicate that while TcdBHV has a
broader cell tropism and is most likely more cytotoxic overall,
TcdBHIST cardiotropism is more pronounced between the two
forms of this toxin.
Comparison of intracellular effects of TcdBHV and
TcdBHIST
We next determined if the variation in cytotoxicity was due to
differences in the cytosolic activities of the two forms of TcdB. As
an approach to this problem we took advantage of a previously
described system used for heterologous delivery of proteins and
protein fragments into the cytosol of target cells [39,40]. This
system is composed of the cell entry components of anthrax lethal
toxin. Briefly, protective antigen (PA) delivers lethal factor (LF)
into the cytosol of mammalian cells. The heterologous delivery
system is derived from the amino-terminus of LF (LFn), which
interacts with PA and can be delivered into cells, but lacks
enzymatic activity. In our experiments, the DNA fragment
encoding the enzymatic domain of TcdB was genetically fused
to lfn, yielding a DNA construct that expresses the cell entry
portion of LF with the enzymatic component of TcdB. This
heterologous delivery system allowed us to regulate the cell entry
of the enzymatic component of TcdBHV and TcdBHIST so that
these domains were identical in the way in which they entered the
cell. We predicted that if the differences in cytotoxicity were due to
factors other than intracellular activity of these forms of TcdB,
then the fusions should exhibit identical cytotoxic effects.
The results of the PA, LFn-TcdB fusion experiments are shown
in Fig. 4. CHO cells were treated with a fixed amount of PA
(500 nM) plus a range of concentrations of LFnTcdBHV(enz) or
LFnTcdBHIST(enz) in order to generate a standard killing curve for
this assay. As controls, CHO cells were treated with PA,
LFnTcdBHV(enz), or LFnTcdBHIST(enz) separately. Following 24 h
of treatment the cells were assayed for viability using WST-8
colorimetric assay and the percent survival was plotted versus
concentration of the fusion protein. Treatment with each of the
components alone had no effect on cell viability in this assay (data
not shown). Treatments with PA plus LFnTcdBHV(enz) or PA plus
LFnTcdBHIST(enz) resulted in similar (p,0.05) cytotoxicity at each
of the concentrations tested (Fig. 4). To confirm that PA was not
limiting in these experiments, cytotoxicity of the fusions was tested
with 10-fold higher amounts of PA, and this additional amount of
PA did not change the level of cytotoxicity for either fusion (data
not shown). The results from this experiment suggested that the
differences in the cytotoxicity of LFnTcdBHV(enz) and
LFnTcdBHIST(enz) were not due to variations in intracellular
activities of the enzymatic domains.
Figure 1. Representation of sequence variation between TcdBHIST and TcdBHV. The illustration depicts TcdBHIST (top) and TcdBHV (bottom)
divided into functional domains: glucosyltransferase (A), cysteine protease (B), translocation (C), and receptor binding (D). (A) Trp 102 and the DXD
motif of the glucosyltransferase domain are conserved between TcdBHIST and TcdBHV. The amino acids making up the substrate recognition region
(SR) show 99% similarity between the strains, and the overall amino acid identity of the domain is 96%. (B) The catalytic triad of the cysteine protease
domain remains unchanged between TcdBHIST and TcdBHV, and the overall identity of the domain is 96%. TcdBHIST contains a cysteine at residue 870,
while TcdBHV contains a tyrosine at residue 870. (C) Amino acid identity of the translocation domain is 91%, with a 97% sequence identity occurring in
the hydrophobic region (HR). TcdBHV contains two cysteines in this domain, which are not found in this region of TcdBHIST. (D) TcdBHIST and TcdBHV
share an identity of 88% in the putative receptor binding domain. Gray boxes symbolize the CROP (clostridial repetitive oligopeptide) regions, 4 large
repeats and 18 small repeats. White boxes indicate TcdBHV CROPs that have less than 80% similarity to TcdBHIST. (E) Coomassie stained SDS-PAGE
analysis of 1 mg of each TcdBHIST and TcdBHV.
doi:10.1371/journal.ppat.1001061.g001
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interaction with CHO cells and cardiomyocytes
The results from the experiment using an identical method of
cell entry, suggested the differences in cytotoxicity might be
associated with early steps in cell binding and cell entry. To
address this hypothesis, we compared the interaction of TcdBHV
and TcdBHIST with cultured cells. Cultured cells were incubated
with Alexa-647-labeled TcdBHV or Alexa-647-labeled TcdBHIST
and the extent of toxin binding was determined by flow cytometry.
This analysis was performed on CHO cell and HL-1 cardiomy-
ocytes. As shown in Fig. 5, CHO cells and HL-1 cells exhibited a
higher degree of fluorescence when incubated with labeled
TcdBHIST than when incubated with labeled TcdBHV. A biphasic
profile was detected in CHO cells with a smaller population of
cells exhibiting a distinct, reduced, toxin-binding pattern. In
contrast, binding to cardiomyocytes was uniform and revealed a
profile expected for a single population of cells.
Experiments were next performed to determine the apparent
Kd for binding of TcdBHIST and TcdBHV. Interestingly, within the
constraints of these experimental conditions we were not able to
achieve saturable binding of either form of the toxin to target cells.
Fig. 5C shows a nearly linear correlation between the increase in
toxin concentration and the mean fluorescence intensity (MFI) of
HL-1 cells despite reaching toxin concentrations of over 300 nM.
Additionally, Fig. 5C further emphasizes the extremely low level of
interaction of TcdBHV with target cells in comparison to the high
MFI achieved with TcdBHIST. These data suggest that cell binding
involves a higher order and more complex process than expected
for a single receptor-ligand interaction.
Rates of cell entry differ between TcdBHIST and TcdBHV
Experiments were next performed to assess the difference in the
rates of cell entry between the two toxins. In previous work on
historical TcdB, we found that lysosomotropic inhibitors could
completely block cytopathic effects of the toxin for up to 16 h,
even if added up to 20 min following exposure of the cells to the
toxin [41]. These findings indicate interaction with the cell,
uptake, and then translocation into the cytosol requires at least
20 min and acidification of endosomes is necessary. To determine
if TcdBHV differed from TcdBHIST in rates of cell entry, cultured
CHO cells were treated with the two forms of the toxin and a
lysosomotropic agent was added to the cells at time-points ranging
from 5 to 60 min following treatment with toxin. The lysosomo-
tropic agent was also added prior to or at the same time cells were
treated with the toxins. The effect of the lysosomotropic agent was
then assessed by determining the level of cytopathic effects (CPE)
either 2 h or 12 h after treatment with the toxin. For this
experiment CPE was determined rather than cytotoxicity due to
toxicity of ammonium chloride at the later time points necessary
for cytotoxicity assays. As shown in Fig. 6, based on the extent of
cell rounding, there appeared to be a clear difference in the rates
of translocation between TcdBHV and TcdBHIST. Unlike our
earlier findings on TcdBHIST, the cytotoxic effects of TcdBHV
could not be prevented when the lysosomotropic agent was added
Figure 2. Representative photographs of zebrafish after 24 h exposure to TcdB. (A) Zebrafish after exposure to 10 nM TcdBHIST. Cardiac
damage is evident by pericardial edema (black arrow) and blood accumulation (white arrow). (B) Exposure to 10 nM TcdBHV causes tissue necrosis
and death of the zebrafish. (C) Zebrafish treated with 1 nM TcdBHIST appear normal, with little to no edema. (D) Zebrafish after exposure to 1 nM
TcdBHV. Arrow indicates damage to the yolk sac, visualized by tissue discoloration and necrosis. (E) Untreated control.
doi:10.1371/journal.ppat.1001061.g002
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Furthermore, addition of the lysosomotropic agent within 10 min
of treatment of TcdBHV only provided a slight delay in CPE, as all
inhibitor treated cells showed complete rounding by 12 h (Fig. 6B).
In contrast, the CPE of TcdBHIST could be prevented by adding
the inhibitor up to 30 min following treatment with the toxin.
These findings indicate TcdBHV translocates to the cytosol more
rapidly than TcdBHIST.
Hydrophobic transitions occur at a higher pH in TcdBHV
Previous studies from our group found that acidic pH triggers
hydrophobic transitions in TcdBHIST [41]. Studies by Barth et al.
found that this hydrophobic transition in TcdB correlated with
membrane insertion by the toxin [42]. These conformational
changes corresponded to the decrease in endosome pH that led to
translocation of the toxin into the cytosol. Thus, it was reasonable
to suspect that TcdBHV translocates more quickly into the cytosol
because the hydrophobic transition was induced at a higher pH
and thus at an earlier stage of endocytosis. To address this
possibility, in the next series of experiments we identified the pH
dependent conformational transitions of TcdBHV by observing
changes in TNS fluorescence when the toxin was incubated at
various pHs. To identify whether TcdBHV exhibits differential
transitions compared to TcdBHIST, the proteins were preincubated
with 150 mM TNS at pH 4.0, 5.0, 6.0, and 7.0, and then analyzed
for changes in TNS fluorescence. As shown in Fig. 7, TcdBHV
exhibited a significant increase in hydrophobicity at pH 5.0, while
TcdBHIST did not undergo this transition until pH 4.0. Further
examination of a narrower pH range revealed that a significant
Figure 3. Comparative dose response of TcdBHIST and TcdBHV. CHO or HL-1 cells were exposed to TcdB for 24 h and cell viability was
determined by WST-8 staining. (A) TcdBHIST (black) and TcdBHV (gray) intoxication of CHO cells. (B) TcdBHIST (black) and TcdBHV (gray) intoxication of
HL-1 cardiomyocyte cells. The error bars represent the standard deviation from the mean of three samples. * p,0.05, *** p,0.001.
doi:10.1371/journal.ppat.1001061.g003
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comparison, TNS fluorescence of TcdBHIST at these pHs was just
above background levels.
These pH transitions were also studied using the inherent
fluorescence of TcdBHIST and TcdBHV from the emission of
tryptophan residues. Unfolding of the hydrophobic region should
expose portions of the protein to a more aqueous environment,
quenching tryptophan fluorescence. Environmental changes
surrounding the tryptophan residues over a broad range of pH
are shown in Fig. 8A and 8B. A gradual quenching of fluorescence
was detected in TcdBHIST from pH 7 to pH 4, while the
tryptophan emission spectra of TcdBHV indicated a sudden shift
between pH 5 and pH 6. Fig. 8D reveals that this shift took place
between pH 5.4 and 5.2, similar to the increase in TNS
fluorescence seen at pH 5.4.
Discussion
In the current study we compared the sequences and activities
of TcdB from hypervirulent and historical strains of C. difficile.
Because TcdB has been shown to be the major virulence factor of
C. difficile [43], we reasoned that changes in the activity of this
toxin could have a profound impact on the severity of disease. The
findings support this notion, as TcdBHV exhibited a broader
tropism and higher potency than TcdBHIST. Among the possible
explanations for this increased toxicity are the observations that
TcdBHV enters cells more rapidly than TcdBHIST, and TcdBHV
undergoes conformational changes at a higher pH than TcdBHIST.
Based on the sequence comparisons and the results of the
experiments using the heterologous delivery system (Figs. 1 and 3),
it appears that the differences in tropism and cytotoxicity are due
to changes in regions outside of the enzymatic domain. Rapid cell
entry could lead to more efficient cell killing by providing the toxin
an endocytic condition in which the toxin is not subject to possible
destruction by lysosomal proteases. The data from the lysosomo-
tropic inhibitor assays (Fig. 6) support the idea that TcdBHV does
not reside within the endosome as long as TcdBHIST. Among the
possible reasons for more rapid cell entry is a differential sensitivity
to levels of IP6 that trigger autoproteolytic processing associated
with translocation. We also noted a difference in the sequence of
the hydrophobic region of TcdB, and if, as has been proposed
[41,42], this region mediates membrane insertion, such differences
could allow TcdBHV to insert into the membrane at an earlier
stage of cell entry. We reasoned that if this possibility were true,
there should be a difference in the pH-induced transitions of the
two forms of TcdB, with the hydrophobic regions of TcdBHV
becoming exposed at a pH higher than the pH necessary for
triggering this transition in TcdBHIST. The results from the TNS
experiments (Fig. 7) indicate that TcdBHV is able to undergo the
hydrophobic transition at a higher pH than TcdBHIST, providing
further evidence that TcdBHV has higher translocation efficiency
than TcdBHIST. Studies looking at the environment surrounding
tryptophan residues of TcdBHIST and TcdBHV at lower pH (Fig. 8)
Figure 4. Heterologous delivery of the TcdB enzymatic domain. CHO cells were treated with LFnTcdBHIST(enz) or LFnTcdBHV(enz) in the
presence of PA for 24 h and cell viability was determined by WST-8 staining. The error bars represent the standard deviation from the mean of three
samples.
doi:10.1371/journal.ppat.1001061.g004
Figure 5. Flow-based analysis of cell binding. TcdBHIST and TcdBHV
were tested for their ability to bind CHO (A) and HL-1 cells (B). 40 nM of
fluorescently labeled TcdB was incubated with cells on ice, and binding
was determined by flow cytometry. TcdBHIST and TcdBHV are indicated,
and shaded peaks represent cells incubated with unlabeled TcdB. (C)
Mean fluorescence intensity (MFI) vs TcdB concentration on HL-1 cells.
Please note the difference in axis for TcdBHIST and TcdBHV.
doi:10.1371/journal.ppat.1001061.g005
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higher pH than TcdBHIST. Additionally, these experiments
revealed that the transition of TcdBHIST occurs gradually, while
TcdBHV demonstrates sudden shifts upon lowering the pH. This
could be indicative of a more efficient unfolding of TcdBHV, which
may contribute to an enhanced ability to traverse the endosomal
membrane. Our current working model is that TcdBHV is able to
translocate at an earlier point in endocytosis and this contributes,
at least in part, to a more efficient intoxication.
We also recognize that the expanded tropism, along with more
efficient cell entry could combine to enhance the in vivo toxicity of
TcdBHV. The results from the zebrafish experiments (Fig. 2)
indicate TcdBHV targets a broader array of cells in vivo than does
TcdBHIST. Defining the specific tropism in the murine model or
an infection model is more difficult, but it is reasonable to consider
the possibility that TcdBHV is more lethal because the toxin targets
an extensive variety of cell types systemically. Unfortunately, the
TcdB receptor has been difficult to identify. Several attempts by
Figure 6. Comparison of the timing of cell entry between TcdBHV and TcdBHIST. CHO cells were pretreated with TcdBHIST or TcdBHV and the
lysosomotropic inhibitor, ammonium chloride, was added at the indicated time points. Cytopathic effects were determined at 2 h (A) and 12 h (B),
and black bars represent cells treated with TcdBHV while gray bars represent TcdBHIST. The error bars mark the standard deviation from the mean. C,
untreated control. I, inhibitor alone. T, TcdB alone.
doi:10.1371/journal.ppat.1001061.g006
Figure 7. TNS analysis of pH-induced hydrophobic transitions in TcdBHIST and TcdBHV. TcdBHIST or TcdBHV was incubated with TNS for
20 min at 37uC. Samples were analyzed for changes in TNS fluorescence, and the emission profile of each pH is shown and labeled. Panels (A) and (B)
represent pH 4.0 to pH 7.0 and panels (C) and (D) show TNS fluorescence of TcdB between pH 5.0 and 6.0. Each spectrum represents the
experimental sample with background (TNS and buffer alone) subtracted.
doi:10.1371/journal.ppat.1001061.g007
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that have been successful with other toxins have failed. The results
from the flow analyses in the current study suggest that the
interaction of TcdB with the cell surface does not fit a single
ligand-receptor model; this observation may explain why it has
been so difficult to identify a receptor for this toxin. We were not
able to achieve saturable binding, and interestingly TcdBHV
interacted less efficiently than TcdBHIST, despite the fact that
TcdBHV is clearly more cytotoxic than TcdBHIST. Undoubtedly,
future studies on characterizing this complex interaction with
target cells will provide important insight into a novel mechanism
of TcdB intoxication.
Previous work by Razaq et al. found that C. difficile BI/NAP1/
027 strains were more lethal than historical strains of C. difficile
[44]. As mentioned in the introduction of this paper, there are
several differences in the phenotypes of the hypervirulent and
historical strains of C. difficile. NAP1 strains sporulate at a higher
efficiency and are resistant to fluoroquinolones. Both of these
characteristics may make the NAP1 strains more difficult to
manage in the hospital setting and increase the frequency of
disease, but are unlikely to increase virulence. Likewise, the binary
toxin has been shown to enhance colonization [13], but clinical
data have revealed little correlation between the increase in disease
severity and production of this toxin [45,46]. In addition, previous
work found binary toxin to be enterotoxic, but strains producing
binary toxin alone did not cause disease in hamsters [47]. Clearly,
an increase in toxin production such as that reported for NAP1
strains could enhance virulence, but a recent report suggests that
the tcdC mutation in epidemic strains does not always correlate
with the overexpression of TcdA and TcdB [48]. Based on the
findings from the current study, we suggest that variations in TcdB
sequence and activity could be an important determining factor in
the hypervirulence of NAP1 strains.
The recent work of Lyras et al. [43] found that TcdB is critical
to C. difficile virulence in a hamster model of CDAD. Thus,
variations in the antigenic region (e.g. carboxy terminus) of TcdB
could allow repeated C. difficile infections of the same host by
strains with antigenic variants of this toxin. In a recent publication
by He and colleagues it was estimated that C. difficile diverged into
a distinct species between 1.1 and 85 million years ago, and has
gone through remarkable genetic variation over time [49]. The
authors also posited that immune selection could have influenced
the genetic variation, and they examined candidate immunogenic
proteins that might fit this profile and 12 such proteins were
identified. TcdB was not among these candidate proteins. It is
unclear whether TcdB fits the criteria established for a positively
selected core gene of C. difficile in this study, but it is reasonable to
suspect the gene may have varied to avoid immune responses and
this hypervariability enriched for a more potent form of the toxin.
It is worth noting that while the protein identity was around 92%,
the DNA homology was 93%. Nearly all of the residue changes
occur as a single nucleotide substitution that result in amino acid
substitutions. This further suggests a possible change in the
sequence of TcdB that has been selected through an enhancement
in virulence and perhaps by immune evasion.
Materials and Methods
Reagents and cell culture
Chinese hamster ovary-K1 (CHO) cells were maintained in F-
12K medium (American Tissue and Culture Collection; ATCC)
along with 10% fetal bovine serum (ATCC). HL-1 cardiomyocytes
Figure 8. Tryptophan emission of TcdBHIST and TcdBHV at acidic and neutral pH. The fluorescent spectrum of each sample is shown and
labeled; each spectrum represents the experimental sample minus background fluorescence of buffer alone. Panels (A) and (B) show tryptophan
emission of TcdBHIST and TcdBHV from pH 4.0 to pH 7.0 while panels (C) and (D) highlight the changes in tryptophan fluorescence between pH 5.0
and pH 6.0.
doi:10.1371/journal.ppat.1001061.g008
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in Claycomb medium (Sigma) supplemented with 10% fetal
bovine serum (ATCC), 0.1 mM Norepinephrine (Sigma), and
2 mM L-glutamine (Invitrogen). Cultures were grown at 37uCi n
the presence of 6% CO2. C. difficile VPI 10463 (produces TcdB
with identical sequence to the 630 strain) and C. difficile BI17 6493
(a gift from Dr. Dale Gerding), were used in this study for the
purification of TcdBHIST and TcdBHV. The tcdB gene was
sequenced from both of these strains and the sequence was
confirmed as exact matches to Genbank deposited sequences of
strain 630 and R20291 (Genbank numbers AM180355 and
FN545816). Cultures were grown as previously described [41],
and TcdB was isolated by consecutive steps of anion-exchange (Q-
Sepharose) and high-resolution anion-exchange (Mono-Q) chro-
matography in 20 mM Tris-HCl, 20 mM CaCl2, pH 8.0.
Purification steps were followed by protein determination using
the Bradford method, visualization of a single band by SDS-
PAGE, and LC/MS/MS analysis (University of Oklahoma Health
Science Center) to confirm protein identity. Cytotoxicity was
determined using a WST-8 [2-(2-methoxy-4-nitrophenyl)-3-
(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium, monosodium
salt] (Dojindo Laboratories) according to manufacturer’s
instructions.
Zebrafish husbandry and experiments
Zebrafish maintenance and experiments were performed in
accordance with the PHS Principles for The Utilization and Care
of Vertebrate Animals Used in Testing, Research, and Training,
and followed the recommendations in the Guide for the Care and
Use of Laboratory Animals under the approval of The University
of Oklahoma Health Sciences Center Campus IACUC (OUHSC
#06-126). Zebrafish were obtained from Aquatic Eco-System
(Apopka, FL). Zebrafish were maintained at 28.5uC on a 14 h
light/10 h dark cycle in 10 gallon tanks equipped with pumps for
mechanical and chemical filtration. Matings were performed in
false bottom tanks, and embryos were washed briefly with 0.5%
bleach after collection. Embryos were incubated in embryo water
(60 mM NaCl, 1.2 mM NaHCO3, 0.9 mM CaCl2, 0.7 mM KCl)
in petri dishes at 28.5uC, and water was changed daily. For TcdB
treatment experiments, embryos were used between 48 and 72 h
post fertilization, with chorions removed. Embryos were placed (5
embryos per well) into 48-well plates and treated with TcdBHIST
or TcdBHV in embryo water at concentrations ranging from
50 nM to 0.01 nM. The embryos were observed for 72 h after
treatment for morphological changes by using a SZX-7 micro-
scope with a DP70 camera (Olympus). All images were captured
and processed by using DP controller and DP manager software
(Olympus).
Construction of LFn-fusions and related assays
The region encoding the enzymatic domain of TcdBHV was
amplified from C. difficile NAP1 genomic DNA by PCR using the
forward primer 59-ACGTCCCGGGATGAGTTTAGTTAATA-
39 and the reverse primer 59-ACTGGATCCTCATTATACTG-
TATTTTG-39 to generate the tcdB gene fragment encoding
residues 1 to 1668 of tcdB (tcdB1–1668) with a 39 XmaI/SmaI and a 59
BamHI site. The restricted gene fragment was fused to lfn by
overnight ligation at 16uC with a Xma1/BamHI-restricted pET15b
derivative containing lfn. The resulting plasmid was cloned into
Escherichia coli XL-1 blue (Novagen) and candidate clones were
screened for the correct insert and orientation by restriction
analysis and DNA sequencing. LFnTcdBHIST(enz) which had been
previously cloned and described [40] and the newly synthesized
LFnTcdBHV(enz) were expressed using E. coli BL-21 Star (Invitro-
gen). Both fusions were purified by Ni
2+ affinity chromatography
(His-Trap, GE Life Sciences) and the purified protein migrated
within the predicted size range of ,94 kDa on SDS-PAGE.
Protective antigen was expressed and purified as previously
described [50].
Cell binding analyses
TcdBHIST or TcdBHV were labeled with Alexa Fluor 647 C5
maleimide (Invitrogen) according to manufacturer’s instructions.
Briefly, a 10 M excess of dye was added to TcdB in 20 mM Tris-
HCl, pH 8.0, and incubated overnight at 4uC. Conjugated protein
was separated from unincorporated dye using Sephadex G-25, and
efficiency of labeling was confirmed to be between 80% and
100%. The activity of labeled TcdB was confirmed by cytotoxicity
on CHO and HL-1 cells and was not reduced by .10%. Binding
of each toxin to CHO and HL-1 cells was examined as follows.
Cells were dissociated from flasks using 1 mM EDTA in PBS,
centrifuged at 5006g, and washed once with PBS. One hundred
thousand cells were incubated with a range from 10 nM to
320 nM of labeled toxin in 1 mL of PBS on ice for 1 h, washed
twice, and the pellets were resuspended in 1 mL of PBS. The
samples were analyzed using a FACSCalibur flow cytometer
(University of Oklahoma Health Sciences Center) and FLOWJO
software (Tree Star, San Carlos, CA). The emission wavelength
was set to 665 nm, and the excitation was set at 633 nm with a
bandpass of 30 nm.
Lysosomotropic inhibitor assays
CHO cells were plated at 5610
4 cells/well in a 96-well plate
and incubated overnight. The following day, TcdBHIST or
TcdBHV was added to the cells at a final concentration of
0.1 mg/mL. At the indicated time points, the cells were washed to
remove unbound toxin, and ammonium chloride (Sigma) was
added to the cells at final concentration of 100 mM. Each sample
was monitored for 24 h, and CPE (cytopathic effect) was
determined by visualization. Percent CPE was calculated by
counting a minimum of 100 cells in 3 different fields for each
sample. Cells scored positive for CPE only when fully rounded,
and the percent CPE was calculated as % rounded cellstest -%
rounded cellscontrol, where control refers to cells treated with media
alone.
TNS assays and tryptophan analysis
2-(p-Toluidinyl) naphthalene-6-sulfonic acid, sodium salt (TNS;
Invitrogen) solutions were prepared to a final concentration of
150 mM in pH specific buffers. For pHs ranging from 4.0 to 6.0,
100 mM NaCl-100 mM ammonium acetate-1 mM EDTA was
used. For pH 6.0 to 7.0, 100 mM NaCl-100 mM MES-1 mM
EDTA was used. For pH 7.0 to 8.0, 100 mM NaCl- 100 mM
HEPES-1mM EDTA was used. 40 pmol of TcdBHIST or TcdBHV
was added to the buffer/TNS mixture in a final volume of 2.5 mL
and allowed to incubate for 20 min and 37uC. Each sample was
analyzed on a Fluorolog R928P PMT fluorometer (HORIBA
Jobin Yvon) with an excitation of 366 nm and an emission scan of
380 to 500 nm with a slit width of 2.0. Tryptophan fluorescence of
TcdBHIST and TcdBHV was also compared in the same manner,
using an excitation of 270 nm and an emission scan of 310 nm to
400 nm.
Statistical analyses
Data are expressed as the means 6 S.E.M. Statistical analyses
were performed using two-tailed unpaired Student’s t-test in
Mechanisms of C. difficile Hypervirulence
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as * p,0.05; ** p,0.01; *** p,0.001.
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